Skip to content
  • Sunday, 26 July 2026
  • 2:13 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Breakthrough in Rare Kidney Cancer Research Reveals How Gene Fusions Drive Tumor Progression via Liquid Condensates
Stem Cell & Regenerative Medicine

Breakthrough in Rare Kidney Cancer Research Reveals How Gene Fusions Drive Tumor Progression via Liquid Condensates

Dwi Wanna Jul 1, 2026 0

In a significant advancement for the field of molecular oncology, a multi-disciplinary team of investigators from the Johns Hopkins Kimmel…

Read More
Stem Cell & Regenerative Medicine

Mapping the Foundations of Human Life First Blueprint of Skeletal Development Unveils Origins of Arthritis and Rare Bone Conditions

Dwi Wanna Jun 24, 2026 0

In a landmark achievement for regenerative medicine and developmental biology, an international consortium of researchers has published the first comprehensive…

Read More
Laboratory Automation & Robotics

How CTF is trying to rescue pharma’s shelved rare disease drugs

Lana Keisha Jun 23, 2026 0

Across the global pharmaceutical landscape, an estimated 5,000 potential treatments for rare diseases are currently languishing on corporate shelves, representing…

Read More
Stem Cell & Regenerative Medicine

Scientists Identify Liquid Condensate Mechanism Driving Rare Kidney Cancer and Potential New Treatment Pathways

Dwi Wanna Jun 23, 2026 0

A collaborative research effort led by scientists at the Johns Hopkins Kimmel Cancer Center and the Johns Hopkins Bloomberg School…

Read More
Stem Cell & Regenerative Medicine

Johns Hopkins Researchers Uncover Molecular Mechanism Driving Rare Translocation Kidney Cancer Through Liquid Condensate Formation

Dwi Wanna Jun 15, 2026 0

In a significant advancement for the field of oncology, investigators at the Johns Hopkins Kimmel Cancer Center and the Johns…

Read More
Laboratory Automation & Robotics

How CTF is trying to rescue pharma’s shelved rare disease drugs

Lana Keisha Jun 15, 2026 0

Across the global pharmaceutical landscape, a staggering number of potentially life-changing therapies for rare diseases lie dormant, gathering dust on…

Read More
Pharmaceutical R&D

Navigating the Diagnostic Labyrinth: Fragmentation Hinders Rare Disease Progress Despite Scientific Leaps

Teuku Ryan Jun 13, 2026 0

The journey from the first symptom of a rare disease to a confirmed diagnosis, often referred to as the "diagnostic…

Read More
Pharmaceutical R&D

Europe Must Rethink Funding and De-Risk Assets to Secure its Rare Disease Research Pipeline

Teuku Ryan Jun 13, 2026 0

The 13th European Conference on Rare Diseases and Orphan Products, held in Prague, Czech Republic, from June 3-4, 2026, served…

Read More
Laboratory Automation & Robotics

How CTF is trying to rescue pharma’s shelved rare disease drugs

Lana Keisha Jun 6, 2026 0

More than 5,000 potentially life-changing treatments for rare diseases are currently languishing on pharmaceutical company shelves, representing a vast reservoir…

Read More
Environmental & Analytical Chemistry

Unraveling the Mysteries of the Bundibugyo Virus: A Race Against a Rare and Deadly Outbreak in the Democratic Republic of Congo

Abdurrohim Arsyad Jun 4, 2026 0

As an Ebola outbreak grows in the Democratic Republic of the Congo, researchers are scrambling to learn more about the…

Read More

Posts pagination

1 2 3 … 5
This breakthrough could finally unlock male birth controlThe Rise of Local AI-Powered Audio Transcription: Enhancing Privacy and Efficiency with Whisper and Faster-WhisperUC Davis Researchers Uncover Light-Induced Shape-Shifting Properties in Halide Perovskites Paving the Way for Advanced Optoelectronic DevicesUCSF Study Reveals Human Lungs as a Major Source of Blood Cells and Stem Cells
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ